Perbedaan Merck Tbk. dan Indo Straits Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Indo Straits Tbk. diperdagangkan di Rp272 (kapitalisasi pasar 147,44 M, volume 24 jam 33,5 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 11,5× kapitalisasi pasar Indo Straits Tbk., dan Merck Tbk. lebih aktif diperdagangkan (37,6 rb vs 33,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | PTIS | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 147,44 M |
Volume | 37,6 rb | 33,5 rb |
Lot | 376 | 335 |
Perputaran | 144,47 jt | 9,03 jt |
Harga Rata-rata | 3.842,23 | 269,52 |
Nilai Transaksi | 144,47 jt | 9,03 jt |
Harga Ekuilibrium Indikatif | 3.840 | 268 |
Volume Ekuilibrium Indikatif | 7 | 400 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Selengkapnya di halaman PTIS →